Umeclidinium Bromide Chemical Structure (Anoro Ellipta Spl Graphic 01)
Anoro Ellipta Powder
Product Images NDC 0173-0869
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Anoro Ellipta (NDC 0173-0869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vilanterol Trifenatate Chemical Structure (Anoro Ellipta Spl Graphic 02)
Figure 1. Impact Of Intrinsic Factors On The Pharmacokinetics (pk) Of Umeclidinium (umec) And Vilanterol (vi) (Anoro Ellipta Spl Graphic 03)
Figure 2. Impact Of Extrinsic Factors On The Pharmacokinetics (pk) Of Umeclidinium (umec) And Vilanterol (vi) (Anoro Ellipta Spl Graphic 04)
Figure 3. Least Squares (ls) Mean Change From Baseline In Postdose Serial Fev1 (ml) On Days 1 And 7, Day 1 (Anoro Ellipta Spl Graphic 05)
Figure 3. Least Squares (ls) Mean Change From Baseline In Postdose Serial Fev1 (ml) On Days 1 And 7, Day 7 (Anoro Ellipta Spl Graphic 06)
Figure 4. Least Squares (ls) Mean Change From Baseline In Postdose Serial Fev1 (0-24 H) (ml) On Days 1 And 28, Day 1 (Anoro Ellipta Spl Graphic 07)
Not Available.*
Figure 4. Least Squares (ls) Mean Change From Baseline In Postdose Serial Fev1 (0-24 H) (ml) On Days 1 And 28, Day 28 (Anoro Ellipta Spl Graphic 08)
Figure 5. Least Squares (ls) Mean Change From Baseline In Fev1 (ml) Over Time (0-24 H) On Days 1 And 168 (trial 1 Subset Population), Day 1 (Anoro Ellipta Spl Graphic 09)
Figure 5. Least Squares (ls) Mean Change From Baseline In Fev1 (ml) Over Time (0-24 H) On Days 1 And 168 (trial 1 Subset Population), Day 168 (Anoro Ellipta Spl Graphic 10)
Inhaler Parts Figure (Anoro Ellipta Spl Graphic 11)
The text is describing two separate items, a "Tray Lid" and a "Carton". It is not possible to determine the specific details or features of these items based on this text alone.*
Figure A (Anoro Ellipta Spl Graphic 12)
Figure B (Anoro Ellipta Spl Graphic 13)
Figure C (Anoro Ellipta Spl Graphic 14)
Figure D (Anoro Ellipta Spl Graphic 15)
Figure E (Anoro Ellipta Spl Graphic 16)
Figure F (Anoro Ellipta Spl Graphic 17)
Figure G (Anoro Ellipta Spl Graphic 18)
This text is a safety instruction advising not to block an air vent with fingers.*
Figure H (Anoro Ellipta Spl Graphic 19)
Figure I (Anoro Ellipta Spl Graphic 20)
Figure J (Anoro Ellipta Spl Graphic 21)
Figure K (Anoro Ellipta Spl Graphic 22)
Anoro Ellipta 30 Dose Carton (Anoro Ellipta Spl Graphic 23)
ANORO Ellipta is a prescription medication that contains a combination of umeclidinium and vilanterol. It comes as an inhalation powder for oral inhalation only. Each strip contains blisters of umeclidinium or vilanterol with magnesium stearate and lactose monohydrate. The product comes with 30 doses and a total of 60 blisters. The NDC code for ANORO Ellipta is 0173-0869-10. It is important to note that it is Rx only, meaning it requires a prescription from a healthcare provider.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
